Literature DB >> 3027825

Liver resection in malignant disease.

W H Edwards, L H Blumgart.   

Abstract

As more surgeons become familiar with the techniques of hepatic resection and the mortality and morbidity decrease, the indications for resection of malignant disease within the liver broadens. The preoperative assessment of malignant liver lesions, as well as the definition of resectability, are outlined. Indications for operative intervention as well as the results obtained are covered. The personal experience of the authors at the Royal Postgraduate Medical School Hepatobiliary Unit, Hammersmith Hospital, in dealing with malignant lesions of the liver is detailed with respect to procedures performed and postoperative morbidity and mortality. Hepatocellular carcinoma, hilar cholangiocarcinoma, and metastatic colon carcinoma are discussed in detail. The authors' experience with each of these diseases is presented.

Entities:  

Mesh:

Year:  1987        PMID: 3027825     DOI: 10.1002/ssu.2980030102

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  5 in total

Review 1.  [Perioperative anesthesia management of extended partial liver resection. Pathophysiology of hepatic diseases and functional signs of hepatic failure].

Authors:  S Herz; G Puhl; C Spies; D Jörres; P Neuhaus; C von Heymann
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

2.  Role of the reverse-Trendelenberg patient position in maintaining low-CVP anaesthesia during liver resections.

Authors:  Zahir F Soonawalla; Charalabos Stratopoulos; Mark Stoneham; Douglas Wilkinson; B Julian Britton; Peter J Friend
Journal:  Langenbecks Arch Surg       Date:  2007-09-06       Impact factor: 3.445

3.  Improvements in survival by aggressive resections of hilar cholangiocarcinoma.

Authors:  H U Baer; S C Stain; A R Dennison; B Eggers; L H Blumgart
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

4.  Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy.

Authors:  T Peter Kingham; Camilo Correa-Gallego; Michael I D'Angelica; Mithat Gönen; Ronald P DeMatteo; Yuman Fong; Peter J Allen; Leslie H Blumgart; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-12-27       Impact factor: 6.113

5.  Defining the risk of liver failure after minor hepatectomy: a NSQIP analysis of 7029 patients.

Authors:  Lily V Saadat; Brian C Brajcich; Yaoming Liu; Clifford Ko; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2020-09-17       Impact factor: 3.647

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.